Citations 6
Efficacy of Mirikizumab in Comparison to Ustekinumab in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3 VIVID-1 Study
Ferrante, M., Kaser, Arthur , Reinisch, Walter, Bragg, S. M., Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Jairath, Vipul , Sands, Bruce E , Bossuyt, Peter , Farraye, Francis A. , Hisamatsu, T., Kierkuś, Jarosław , Laharie, David , Siegmund, Britta , Hon, Kam‐Lun Ellis , Morris, Nathan , Danese, Silvio
Zeitschrift für Gastroenterologie | November 27, 2025 | Volume: 62 | Issue: 05 | Pages: e481-e482
P68 Mirikizumab versus placebo: histologic inflammation in 5 intestinal segments in randomized controlled phase 3 trial for crohn’s disease participants
Feagan, Brian G., Hisamatsu, Tadakazu , D’Haens, Geert , Pai, Rish K. , Lin, Zhantao, Protić, Marijana , Hon, Emily, Escobar, Rodrigo , Reinisch, Walter , Dhesi, Endip , Jairath, Vipul , Magro, Fernando , Hertogh, Gert D. , Harpaz, Noam , Morris, Nathan , Owen, Charles, Reinisch, Walter
Posters | June 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: A129.2-A130
S1329 Effects of Mirikizumab versus Placebo on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized, Controlled Phase 3 Trial of Participants With Crohn’s Disease
Jairath, Vipul , Feagan, Brian G. , Hisamatsu, Tadakazu , D’Haens, Geert , Pai, Rish K. , Lin, Zhantao, Protić, Marijana , Hon, Emily, Owen, Charles , Escobar, Rodrigo , Reinisch, Walter , Jairath, Vipul , Jairath, Vipul , Jairath, V , Jairath, V , Jairath, Vipul , Magro, Fernando , Hertogh, Gert D. , Harpaz, Noam , Morris, Nathan , Reinisch, Walter
American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S952-S953
S1330 Effects of Mirikizumab and Ustekinumab on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized Controlled Phase 3 Trial of Participants With Crohn’s Disease
Jairath, Vipul , Feagan, Brian G. , Hisamatsu, Tadakazu , D’Haens, Geert , Pai, Rish K. , Lin, Zhantao, Protić, Marijana , Hon, Emily, Owen, Charles , Escobar, Rodrigo , Reinisch, Walter , Jairath, Vipul , Jairath, Vipul , Jairath, V , Jairath, V , Jairath, Vipul , Magro, Fernando , Hertogh, Gert D. , Harpaz, Noam , Morris, Nathan , Reinisch, Walter
American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S953-S953
P115 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate-to-severe Crohn’s disease: results from phase 3 VIVID 1 study
Sands, Bruce E, Ferrante, Marc, Hisamatsu, Tadakazu , Kaser, Arthur , Reinisch, Walter , Bragg, Sonja M., Hon, Emily, Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Dhesi, Endip , Jairath, Vipul , Bossuyt, Peter , Farraye, Francis A. , Kierkuś, Jarosław , Laharie, David , Reinisch, Walter , Siegmund, Britta , Morris, Nathan , Danese, Silvio
Poster Presentations | July 1, 2024 | Volume: No volume available | Issue: No issue available | Pages: A120.1-A120
S982 Association of Histologic-Endoscopic Response and Long-Term Clinical Outcomes: Results From Phase 2 Mirikizumab Trial in Patients With Moderately-to-Severely Active Crohn’s Disease
Protić, Marijana , Reinisch, Walter , Pai, Rish K. , Lin, Zhantao, Hozak, Rebecca R., Carlier, Hilde, Margo, Fernando, Jairath, Vipul , Reinisch, Walter , Hertogh, Gert D. , Harpaz, Noam
American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S740-S741